Shares in medtech company have lost almost half their value since its flotation in late 2021, amid a number of revisions of targets
HealthBeacon also said that its ARR run rate will now be about €17 million by the fourth quarter of next year, down from a previous target of €25 million.
Ms Shanahan’s firm, Florida-based Shanahan Capital Ventures, focuses on developing, scaling and restructuring healthcare businesses and supporting investors in the acquisition, growth and sale of healthcare assets. She has previously served in leadership roles in companies including Avella Specialty Pharmacy, Aetna Specialty Pharmacy, Oncology Therapeutic Network, Shopper’s Drug Mart, and Cardinal Health.
HealthBeacon widened its partnership with Hamilton Beach earlier this year to also include management of its supply chain in the US as sought to rein in costs and move along the path to profitability.